Metraipolis › archive › dc_0359083947cb
Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025 — Europe PMC PMID:41320971
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41320971
- DOI
- 10.1111/irv.70186
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T01:39:46.507Z
- SHA-256 of the archived text
410ad3a74dfceb95ca00cc3425fdd6979c41ffe1cde5206e4572341799780641- Stable URL of this page
https://metraipolis.com/documento/dc_0359083947cb
How to cite
Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025 — Europe PMC PMID:41320971 — Europe PMC (en), https://europepmc.org/article/MED/41320971 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0359083947cb (Metraipolis archive dc_0359083947cb, sha256 410ad3a74dfceb95ca00cc3425fdd6979c41ffe1cde5206e4572341799780641)
BibTeX
@misc{dc0359083947cb,
title = {Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025 — Europe PMC PMID:41320971},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41320971},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0359083947cb; sha256 410ad3a74dfceb95ca00cc3425fdd6979c41ffe1cde5206e4572341799780641},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41320971. Agents can read the archived copy with the MCP tool read_document.